Literature DB >> 22210666

Musculoskeletal manifestations of mucopolysaccharidoses.

Kimberly Morishita1, Ross E Petty.   

Abstract

The mucopolysaccharidoses (MPSs) are a heterogeneous group of inherited metabolic disorders caused by enzyme deficiencies that lead to progressive lysosomal storage of glycosaminoglycans. Musculoskeletal manifestations are common across all forms of MPS and are often apparent early in the disease course. Diagnostic delays occur frequently in these patients, especially those with more attenuated forms of disease. Treatments for many types of MPS are now available; however, they are most effective if started early before the development of irreversible damage. Some manifestations such as stiffness and joint contractures may mimic other conditions such as inflammatory arthritis, which may cause further delays. Rheumatologists and other specialists should be aware of the musculoskeletal manifestations of MPS so that diagnostic delays can be avoided and appropriate management initiated.

Entities:  

Mesh:

Year:  2011        PMID: 22210666     DOI: 10.1093/rheumatology/ker397

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  29 in total

1.  Growth in patients with mucopolysaccharidosis type III (Sanfilippo disease).

Authors:  J de Ruijter; L Broere; M F Mulder; A T van der Ploeg; M E Rubio-Gozalbo; S B Wortmann; G Visser; F A Wijburg
Journal:  J Inherit Metab Dis       Date:  2013-10-31       Impact factor: 4.982

2.  β-Glucuronidase, a Regulator of Lyme Arthritis Severity, Modulates Lysosomal Trafficking and MMP-9 Secretion in Response to Inflammatory Stimuli.

Authors:  Kenneth K C Bramwell; Kelton Mock; Ying Ma; John H Weis; Cory Teuscher; Janis J Weis
Journal:  J Immunol       Date:  2015-07-13       Impact factor: 5.422

3.  Lysosomal β-glucuronidase regulates Lyme and rheumatoid arthritis severity.

Authors:  Kenneth K C Bramwell; Ying Ma; John H Weis; Xinjian Chen; James F Zachary; Cory Teuscher; Janis J Weis
Journal:  J Clin Invest       Date:  2013-12-16       Impact factor: 14.808

Review 4.  Nucleic Acid-Sensing Receptors: Rheostats of Autoimmunity and Autoinflammation.

Authors:  Shruti Sharma; Katharine A Fitzgerald; Michael P Cancro; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2015-10-15       Impact factor: 5.422

Review 5.  Hurdles in treating Hurler disease: potential routes to achieve a "real" cure.

Authors:  Brigitte T A van den Broek; Jaap van Doorn; Charlotte V Hegeman; Stefan Nierkens; Caroline A Lindemans; Nanda Verhoeven-Duif; Jaap Jan Boelens; Peter M van Hasselt
Journal:  Blood Adv       Date:  2020-06-23

Review 6.  Upper Extremity Compressive Neuropathies in the Pediatric and Adolescent Populations.

Authors:  Casey M Codd; Joshua M Abzug
Journal:  Curr Rev Musculoskelet Med       Date:  2020-12

7.  Isokinetic muscle strength differences in patients with mucopolysaccharidosis I, II, and VI.

Authors:  Natalie E Taylor; Donald R Dengel; Troy C Lund; Kyle D Rudser; Paul J Orchard; Julia Steinberger; Chester B Whitley; Lynda E Polgreen
Journal:  J Pediatr Rehabil Med       Date:  2014

8.  Evaluation of spinal involvement in children with mucopolysaccharidosis VI: the role of MRI.

Authors:  Elif Bulut; Emine Pektas; Hatice S Sivri; Burcak Bilginer; Mumtaz M Umaroglu; Burce Ozgen
Journal:  Br J Radiol       Date:  2018-02-13       Impact factor: 3.039

Review 9.  Mucopolysaccharidoses.

Authors:  Rolando Cimaz; Francesco La Torre
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

10.  In silico approach to explore the disruption in the molecular mechanism of human hyaluronidase 1 by mutant E268K that directs Natowicz syndrome.

Authors:  D Meshach Paul; R Rajasekaran
Journal:  Eur Biophys J       Date:  2016-07-16       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.